GR3022895T3 - Phosphoinositolglycan-peptide with insulin like activity - Google Patents

Phosphoinositolglycan-peptide with insulin like activity

Info

Publication number
GR3022895T3
GR3022895T3 GR970400577T GR970400577T GR3022895T3 GR 3022895 T3 GR3022895 T3 GR 3022895T3 GR 970400577 T GR970400577 T GR 970400577T GR 970400577 T GR970400577 T GR 970400577T GR 3022895 T3 GR3022895 T3 GR 3022895T3
Authority
GR
Greece
Prior art keywords
phosphoinositolglycan
insulin
peptide
activity
inositol
Prior art date
Application number
GR970400577T
Other languages
English (en)
Inventor
Guenter Dr Mueller
Dominique Dr Tripier
Stefan Dr Muellner
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of GR3022895T3 publication Critical patent/GR3022895T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1027—Tetrapeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
GR970400577T 1991-08-20 1997-03-24 Phosphoinositolglycan-peptide with insulin like activity GR3022895T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4127495 1991-08-20

Publications (1)

Publication Number Publication Date
GR3022895T3 true GR3022895T3 (en) 1997-06-30

Family

ID=6438668

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970400577T GR3022895T3 (en) 1991-08-20 1997-03-24 Phosphoinositolglycan-peptide with insulin like activity

Country Status (22)

Country Link
US (1) US5624903A (el)
EP (1) EP0532915B1 (el)
JP (1) JP3361126B2 (el)
KR (2) KR100264623B1 (el)
AT (1) ATE147407T1 (el)
AU (1) AU656396B2 (el)
CA (1) CA2076424C (el)
CZ (1) CZ290341B6 (el)
DE (1) DE59207835D1 (el)
DK (1) DK0532915T3 (el)
ES (1) ES2096686T3 (el)
FI (1) FI102842B (el)
GR (1) GR3022895T3 (el)
HR (1) HRP940834B1 (el)
HU (1) HU210431B (el)
IL (1) IL102859A (el)
NO (1) NO303452B1 (el)
SG (1) SG46639A1 (el)
SK (1) SK281333B6 (el)
TW (1) TW224104B (el)
YU (1) YU66892A (el)
ZA (1) ZA926232B (el)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE184611T1 (de) * 1991-11-29 1999-10-15 Hoechst Ag Peptide mit insulinartiger wirkung
ES2159283T3 (es) * 1992-02-29 2001-10-01 Aventis Res & Tech Gmbh & Co Complejos que contienen glicosil-fosfatidilinositol-proteinas y derivados de acido colanico, procedimiento para su preparacion y su utilizacion.
US5652221A (en) * 1994-11-07 1997-07-29 The University Of Virginia Patent Foundation Method of treating defective glucose metabolism using synthetic insulin substances
GB9618929D0 (en) 1996-09-11 1996-10-23 Univ London Metal containing carbohydrates from human tissue which regulate glycogen metabolism
GB9618934D0 (en) * 1996-09-11 1996-10-23 Univ London Inositol phosphoglycans for therapeutic use in the treatment of diabetes and obesity
GB9618930D0 (en) 1996-09-11 1996-10-23 Univ London Metal containing carbohydrates from human tissue which regulate lipogenic activity
DE19649350A1 (de) * 1996-11-28 1998-06-04 Hoechst Ag Inositolglykane mit insulinartiger Wirkung
KR100481746B1 (ko) * 1996-11-28 2005-08-10 훽스트 악티엔게젤샤프트 인슐린-유사작용을갖는이노시톨글리칸및이를포함하는약제학적제제
EP2158923B1 (en) 1998-08-06 2013-02-27 Mountain View Pharmaceuticals, Inc. Peg-urate oxidase conjugates and use thereof
CH697081A5 (de) * 2002-01-22 2008-04-30 Andreas F Dr Schaub Zusammensetzung für die Unterstützung der Geburt eines menschlichen Föten.
EP1378517A1 (en) * 2002-07-05 2004-01-07 Aventis Pharma Deutschland GmbH Phosphoinositolglycan (PIG) binding protein from adipocytes
CA2491555C (en) * 2002-07-10 2012-09-11 Massachusetts Institute Of Technology Solid-phase and solution-phase synthesis of glycosylphosphatidylinositol glycans
ITMI20030237A1 (it) * 2003-02-11 2004-08-12 Indena Spa Uso della conglutina di lupino per il trattamento del
DE102004054552A1 (de) * 2004-11-11 2006-05-18 Hcb Happy Child Birth Holding Ag Neue Zusammensetzung zur Erleichterung der Humangeburt
RU2435847C2 (ru) 2005-04-11 2011-12-10 Савиент Фармасьютикалз, Инк. Вариантная форма урат-оксидазы и ее использование
PL3321359T3 (pl) 2005-04-11 2021-06-28 Horizon Pharma Rheumatology Llc Wariantowe postacie oksydazy moczanowej i ich zastosowanie
US8148123B2 (en) 2005-04-11 2012-04-03 Savient Pharmaceuticals, Inc. Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
KR101861547B1 (ko) 2009-06-25 2018-07-02 크레알타 파마슈티칼스 엘엘씨 페길화된 유리카아제 치료 중에 혈청 요산을 모니터링하여 주입 반응의 위험성 및 반응의 항체­매개 상실을 예측하는 방법 및 키트
CN102270762B (zh) * 2010-06-03 2014-08-20 清华大学 锂离子电池电极浆料及应用该电极浆料制备的电极片

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
DE3326472A1 (de) * 1983-07-22 1985-02-14 Hoechst Ag, 6230 Frankfurt Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus
US4906468A (en) * 1986-04-11 1990-03-06 The Rockefeller University Insulin activity messengers, their antibodies, and thereof
US4839466A (en) * 1986-04-11 1989-06-13 The Rockefeller University Insulin activity messengers

Also Published As

Publication number Publication date
ATE147407T1 (de) 1997-01-15
SG46639A1 (en) 1998-02-20
NO923252L (no) 1993-02-22
AU656396B2 (en) 1995-02-02
AU2110992A (en) 1993-02-25
DE59207835D1 (de) 1997-02-20
FI923702A (fi) 1993-02-21
EP0532915B1 (de) 1997-01-08
JP3361126B2 (ja) 2003-01-07
HRP940834B1 (en) 2000-08-31
CA2076424A1 (en) 1993-02-21
NO303452B1 (no) 1998-07-13
JPH05301891A (ja) 1993-11-16
EP0532915A2 (de) 1993-03-24
FI923702A0 (fi) 1992-08-18
YU66892A (sh) 1995-10-24
IL102859A0 (en) 1993-01-31
HUT62013A (en) 1993-03-29
DK0532915T3 (da) 1997-07-07
TW224104B (el) 1994-05-21
ZA926232B (en) 1993-04-28
CZ255392A3 (en) 1993-03-17
CZ290341B6 (cs) 2002-07-17
KR100318706B1 (ko) 2001-12-28
ES2096686T3 (es) 1997-03-16
HRP940834A2 (en) 1997-04-30
EP0532915A3 (en) 1994-05-18
IL102859A (en) 1998-12-27
SK255392A3 (en) 1995-02-08
FI102842B1 (fi) 1999-02-26
NO923252D0 (no) 1992-08-19
FI102842B (fi) 1999-02-26
KR930004327A (ko) 1993-03-22
SK281333B6 (sk) 2001-02-12
CA2076424C (en) 2003-06-03
US5624903A (en) 1997-04-29
KR100264623B1 (ko) 2000-09-01
HU210431B (en) 1995-04-28

Similar Documents

Publication Publication Date Title
EP0532915A3 (en) Phosphoinositolglycan-peptide with insulin like activity
CA2029596A1 (en) Medicaments containing r-a-lipoic acid
AU568067B2 (en) Oligonucleotide therapeutic agent and methods of making same
NZ294743A (en) A formulation for administering transdermally a protein or polypeptide such as insulin
AU8163394A (en) Treatment of diabetes by administration of myo-inositol
ATE44649T1 (de) Glykosylierte insulinabkoemmlinge.
AU601280B2 (en) Mixed crystals of insulin and insulin derivatives, a process for the preparation of these mixed crystals, pharmaceutical agents containing these mixed crystals, and the use thereof for the treatment of diabetes mellitus
IL79433A0 (en) Aromatic compounds,their preparation and their use as pesticides
IL75826A0 (en) Aromatic compounds,their preparation and their use as pesticides
AU5973594A (en) Syringe for administering a given number of injections
EP0193910A3 (en) Synthesis of a derivative of grf and intermediate peptides
AU3674889A (en) Peptide molecules with activity against gram positive microorganisms
EP0416604A3 (en) Paf-antagonists for the preparation of a medicament, useful for the treatment of heart diseases, caused by diminished beta-receptor-stimulation
CA2058020A1 (en) Short peptides with insulin activity
MY103751A (en) Heterobicycloalkanes having pesticidal activity
HUT47205A (en) Stabilized solid insecticides containing as active substance s,s'-(2)dimethyl-amin(-trimethilen-)bis-(benzosulphonate)
ES8708180A1 (es) Procedimiento de obtencion de composiciones insecticidas, a base de un piretroide
AU542310B2 (en) Glicentin related purified peptide having 30 amino acids
AU5110390A (en) Cdna coding for placental protein 9 (pp9), the isolation and use thereof
ZA934719B (en) 3,4,5-Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicament containing them